Cardiovascular Outcomes With Anti-Inflammatory Therapies: Review of Literature |
| |
| Affiliation: | 1. University of Central Florida College of Medicine, Graduate Medical Education, Orlando, FL;2. Ocala Regional Medical Center, Internal Medicine Residency Program, Ocala, FL;1. Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Republic of Armenia;2. Corresponding Member of Russian Academy of Science, Scientific Director of Research Institute of Human Morphology, President of Russian Society of Pathology, Moscow, Russian Federation;3. School of Medicine, Isfahan University of Medical Sciences. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran;4. “National Medical Research Center of Cardiology” of the Ministry of Health of Russia, Moscow, Russian Federation;5. Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran;1. Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE;2. Division of Cardiology, University of Nebraska Medicine, Omaha, NE;3. Division of Cardiology, Creighton University School of Medicine, Omaha, NE;1. Department of Medical Strategy, MEDICUS, Buenos Aires, Argentina;2. Department of Internal Medicine, Hospital Alemán, Buenos Aires, Argentina;3. Coronary Care Unit and Heart Failure Division, Juana Cabral Cardiovascular Institute, Corrientes, Argentina;4. Argentine Federation of Cardiology, Corrientes, Argentina;5. Department of Clinical Research, Hospital Cesar Milstein, Buenos Aires, Argentina;6. Gene Therapies, Novartis, Buenos Aires, Argentina;7. Geriatric Program, Ministry of Health, Salta, Argentina;8. Division of Cardiology, Centro de Investigaciones Metabólicas, Buenos Aires, Argentina;9. Department of Cardiology, Hospital Santojanni, Buenos Aires, Argentina;10. Argentine Society of Cardiology, Buenos Aires, Argentina;11. Centro de Especialidades Médicas, Buenos Aires, Argentina;12. Heart Failure Therapeutic Area, Novartis;13. Geriatric Unit, Hospital Alemán, Buenos Aires, Argentina;1. Department of Cardiopulmonary Emergencies and Pulmonary Vascular Disorders Clinic, Hospital General de México “Dr Eduardo Liceaga,” Mexico City, Mexico;2. Department of Medicine, Divisions of Hospital and Adult Thrombosis Medicine, Texas Tech University Health Sciences Center and Paul L. Foster School of Medicine, El Paso, Texas, USA;3. Division of Cardiovascular Diseases, Texas Tech University Health Sciences Center and Paul L. Foster School of Medicine, El Paso, Texas, USA;4. Faculty of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico;5. Department of Radiology, I.M. Sechenov First Moscow State Medical University (Sechenov?University), Moscow, Russia;6. Directorate of Research, Hospital General de Mexico “Dr Eduardo Liceaga,” 06720, Mexico City, Mexico;1. John Ochsner Heart and Vascular Institute, Ochsner Medical Center, New Orleans, LA;2. The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA;3. Division of Internal Medicine, Ochsner Medical Center, New Orleans, LA;4. Section of Cardiomyopathy & Heart Transplantation, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA;1. Division of Cardiology, Creighton University School of Medicine, Omaha, NE;2. Department of Medicine, Creighton University School of Medicine, Omaha, NE;3. Creighton University School of Pharmacy and Health Professions, Omaha, NE;4. John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA |
| |
| Abstract: | Inflammation is a major contributing factor in the development of cardiovascular disease (CVD) and has been a popular topic of discussion as it provides a potential therapeutic target to reduce disease progression. Multiple inflammatory markers have been linked with progressive atherosclerosis which includes interleukin-6, tumor necrosis factor-α, C-reactive protein amongst others, this article aims to review current literature to evaluate the effectiveness of anti-inflammatory therapies in cardiovascular disease. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
